세계의 스포츠 의학 시장 : 제품별, 용도별, 최종사용자별 - 예측(-2029년)

The global sports medicine market is expected to reach USD 9.45 Billion by 2029 from USD 6.79 Billion in 2024, growing at a CAGR of 6.8% during the forecast period. The anticipated market growth for sports medicine market is supported by significant progress made in the field. The factors enhancing the demand comprise innovation and improvements in technologies, improved therapeutic efficiency and uptake of major initiatives by government to increase the physical activity of citizens as well as to prevent sports related injuries. The limitations are the high cost of medical devices associated with sports medicine that may restrict many people in need from accessing such therapies.

"Body reconstruction products to register largest market share in 2022-2029."

Body reconstruction products include implants, fracture & ligament repair products, arthroscopy devices, prosthetics and orthobiologics. Products for body reconstruction include prosthesis, arthroscopy equipment, implants, fracture and ligament repair supplies, and guthobiologics. Numerous contact sports, including basketball, rugby, and football, entail injuries that necessitate reconstruction, muscle or tendon fix, or replacement of the complete bone or cartilage tissue. To restore strength to large regions, implants may be used in a number of cases to replace missing bone. Furthermore, the injured site may also require the utilization of scaffold reconstruction material and OrthoBiologics. The frequency of fractures and ligament damage has gone up over time. Sports injuries involving the anterior cruciate ligament (ACL) are by far the most frequent. Meniscus, rotator cuff, and cartilage repairs are the three primary surgical techniques for ACL injuries. Repairing meniscals is the most typical process performed on the knee.

"Physiotherapy centers and clinics to register highest growth rate in the market during the forecast period."

Physiotherapy centers offer support and promote health of an individual's lifestyle. Physiotherapists utlizes exercises and help to recover physical and mental well-being. There are various advantages associated with this segment. It can decrease pain, enhance joint movement, give strength, reduce inflammation, and betters cardio-respiratory role of the patient.

"Asia Pacific to register highest growth rate in the market during the forecast period."

The highest CAGR was registered by the APAC region throughout the forecast period from 2024-2029. Asia Pacific comprise India, China, Japan, Australia, South Korea and RoAPAC. The Asia-Pacific region has shown significance growth for sports medicine market. Asia Pacific is projected to grow at a highest rate in sports medicine market for numerous reasons. Most importantly, sports medicine products are in high demand due to increase in participation in outdoor sports activities for professional or recreational purpose. Rise in fundings and increase in participation in different sports events such as Olympics are enhancing the growth of sports medicine market.

A number of drivers were responsible for the upswing, including:

A breakdown of the primary participants referred to for this report is provided below:

• By Company Type: Tier 1-30%, Tier 2-42%, and Tier 3- 28%
• By Designation: C-level-- 10%, Director-level-14%, and Others-76%
• By Region: North America-40%, Europe-30%, Asia Pacific-22%, Rest of the World -8%.

Prominent players in this market are Smith & Nephew (UK), DePuy Synthes (US), Stryker (US), Breg, Inc. (US), Conmed Corporation (US), Zimmer Biomet Holdings, INC. (US), Enovis (US), RTI Surgical (US), Performance Health International Limited (US), Bauerfeind AG (Germany), Arthrex, INC. (US), Karl Stprz GMBH & CP. KG (Germany), Mueller Sports Medicine, INC. (US), Ossur (Iceland), Ottobock SE & CO. KGAA (Germany), Biotek (India), Anika Therapeutics (US) among others.

Research Coverage

Products, applications, end users, and regions are the basis for the segmentation. The drivers, constraints, opportunities, and challenges that affect the market's growth are all examined in this study. For stakeholders, the report outlines the prospects and challenges in the sports medicine sector. There are also more specifics on competitive landscapes of key players. This study assesses micro markets in terms of their potential, growth trends, and contributions to the global sports medicine industry. With a focus on five key regions, the report projects a rise in market segment revenues.

Key Benefits of Buying the Report:

The report aims to assist new entrants and top players in the in sports medicine market in understanding the sustainability of investments. It also addresses the availability of comprehensive data for these purposes. These are the main benefits of purchasing the report. It will support thorough risk assessment procedures and investment decision-making. It provides accurate market segmentation, such as that based on end users and geographic factors, providing targeted segments with customized information. Additionally, it assesses the most important trends, difficulties, growth factors, and opportunities related to the same, enabling intelligent judgment and strategic decision-making.

The report provides the insights on the following pointers:

Analysis of the key drivers, restraints, opportunities, and challenges affecting the growth of the sports medicine market: Innovative technology and rise in cases of sports injury; high cost of devices and strict regulations; growing number of hospitals and increased therapies.

Product Development/Innovation: Overview of pipeline technologies, research & development endeavors and introduction of novel product & service for the sports medicine industry.

Market Development: Comprehensive details regarding profitable markets: the study examines the sports medicine business in several geographical areas.

Market Diversification: Thorough understanding of novel products, unexplored regions, current advancements, and investments in the sports medicine market.

Competitive Assessment: Detailed assessment of market share, service offerings leading strategies of key players such as Smith & Nephew (UK), DePuy Synthes (US), Stryker (US), Zimmer Biomet Holdings, INC. (US) and Arthrex, INC. (US).

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 INCLUSIONS AND EXCLUSIONS
• 1.4 STUDY SCOPE
  • 1.4.1 MARKETS COVERED
  • 1.4.2 YEARS CONSIDERED
  • 1.4.3 CURRENCY CONSIDERED
• 1.5 STAKEHOLDERS
• 1.6 SUMMARY OF CHANGES
• 1.7 IMPACT OF GEN AI

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
• 2.2 RESEARCH DESIGN
  • 2.2.1 SECONDARY RESEARCH
  • 2.2.2 PRIMARY RESEARCH
    • 2.2.2.1 Primary sources
    • 2.2.2.2 Key industry insights
• 2.3 MARKET SIZE ESTIMATION
  • 2.3.1 BOTTOM-UP APPROACH
    • 2.3.1.1 Company revenue estimation approach
    • 2.3.1.2 Customer-based market estimation approach
  • 2.3.2 TOP-DOWN APPROACH
    • 2.3.2.1 Primary interviews
    • 2.3.2.2 CAGR projections
• 2.4 DATA TRIANGULATION
• 2.5 MARKET SHARE ASSESSMENT
• 2.6 RESEARCH ASSUMPTIONS
  • 2.6.1 METHODOLOGY-RELATED ASSUMPTIONS
• 2.7 RESEARCH LIMITATIONS
• 2.8 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 SPORTS MEDICINE MARKET OVERVIEW
• 4.2 SPORTS MEDICINE MARKET, BY REGION
• 4.3 ASIA PACIFIC SPORTS MEDICINE MARKET, BY COUNTRY AND END USER
• 4.4 SPORTS MEDICINE MARKET, BY KEY COUNTRY

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Rising incidence of sports injuries
    • 5.2.1.2 Increasing innovations in products and treatments
    • 5.2.1.3 Growing adoption of 3D printing
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 High cost of implants and other devices
    • 5.2.2.2 Elevated risk of complications in sports injuries
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Emerging sports leagues and events
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Risks associated with invasive injuries
• 5.3 INDUSTRY TRENDS
  • 5.3.1 ROBOTIC SURGICAL SYSTEMS FOR ORTHOPEDICS
  • 5.3.2 REGENERATIVE MEDICINE
  • 5.3.3 BIOMECHANICS AND MOTION ANALYSIS
• 5.4 VALUE CHAIN ANALYSIS
  • 5.4.1 RESEARCH & DEVELOPMENT
  • 5.4.2 RAW MATERIAL PROCUREMENT AND MANUFACTURING
  • 5.4.3 MARKETING & SALES, DISTRIBUTION, AND POST-SALES SERVICES
• 5.5 PORTER'S FIVE FORCES ANALYSIS
  • 5.5.1 THREAT OF NEW ENTRANTS
  • 5.5.2 THREAT OF SUBSTITUTES
  • 5.5.3 BARGAINING POWER OF SUPPLIERS
  • 5.5.4 BARGAINING POWER OF BUYERS
  • 5.5.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.6 PATENT ANALYSIS
• 5.7 KEY CONFERENCES AND EVENTS, 2024-2025
• 5.8 TRADE DATA ANALYSIS
  • 5.8.1 IMPORT DATA
  • 5.8.2 EXPORT DATA
• 5.9 PRICING ANALYSIS
  • 5.9.1 AVERAGE SELLING PRICE TREND, BY REGION
  • 5.9.2 AVERAGE SELLING PRICE TREND OF TOP 3 APPLICATIONS, BY KEY PLAYER
• 5.10 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.10.2 BUYING CRITERIA
• 5.11 UNMET NEEDS AND KEY PAIN POINTS
• 5.12 ECOSYSTEM ANALYSIS
• 5.13 SUPPLY CHAIN ANALYSIS
  • 5.13.1 PROMINENT COMPANIES
  • 5.13.2 SMALL AND MEDIUM-SIZED ENTERPRISES
  • 5.13.3 END USERS
• 5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESSES
• 5.15 TECHNOLOGY ANALYSIS
  • 5.15.1 KEY TECHNOLOGIES
    • 5.15.1.1 Wearable technology
    • 5.15.1.2 Rehabilitation technology
    • 5.15.1.3 Artificial intelligence and machine learning
    • 5.15.1.4 3D printing and customization
  • 5.15.2 COMPLEMENTARY TECHNOLOGIES
    • 5.15.2.1 Biomechanics analysis
    • 5.15.2.2 Regenerative medicine
    • 5.15.2.3 Virtual reality and augmented reality
  • 5.15.3 ADJACENT TECHNOLOGIES
    • 5.15.3.1 Fitness and health apps
    • 5.15.3.2 Telehealth platforms
    • 5.15.3.3 Internet of Things
    • 5.15.3.4 Data analytics and performance management software
    • 5.15.3.5 Genomics and personalized medicine
• 5.16 CASE STUDY ANALYSIS
  • 5.16.1 ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION AND CHONDROPLASTY OF KNEE
  • 5.16.2 EFFECTIVENESS OF OSTEOPATHY IN TREATING SPORTS INJURIES
  • 5.16.3 TOTAL HIP REPLACEMENT WITH AVASCULAR NECROSIS
• 5.17 REGULATORY LANDSCAPE
  • 5.17.1 REGULATORY STANDARDS AND APPROVALS
    • 5.17.1.1 North America
      • 5.17.1.1.1 US
      • 5.17.1.1.2 Canada
    • 5.17.1.2 Europe
    • 5.17.1.3 Asia Pacific
      • 5.17.1.3.1 Japan
      • 5.17.1.3.2 China
      • 5.17.1.3.3 India
  • 5.17.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• 5.18 INVESTMENT AND FUNDING SCENARIO
• 5.19 REIMBURSEMENT SCENARIO
• 5.20 IMPACT OF GEN AI ON SPORTS MEDICINE MARKET

6 SPORTS MEDICINE MARKET, BY APPLICATION

• 6.1 INTRODUCTION
• 6.2 KNEE INJURIES
  • 6.2.1 GROWING CASES OF COLLATERAL LIGAMENT INJURIES AND TENDON TEARS TO FUEL MARKET
• 6.3 SHOULDER INJURIES
  • 6.3.1 ADVANCEMENTS IN ARTHROSCOPIC SURGICAL TECHNOLOGY TO AID GROWTH
• 6.4 FOOT & ANKLE INJURIES
  • 6.4.1 RISING PREFERENCE FOR FOOT & ANKLE RECONSTRUCTIONS TO AUGMENT GROWTH
• 6.5 HIP & GROIN INJURIES
  • 6.5.1 SURGE IN OSTEOARTHRITIS CASES TO FACILITATE GROWTH
• 6.6 ELBOW & WRIST INJURIES
  • 6.6.1 INCREASED HEALTHCARE EXPENDITURE TO EXPEDITE GROWTH
• 6.7 BACK & SPINE INJURIES
  • 6.7.1 RISING EMPHASIS ON ENHANCING PATIENT OUTCOMES TO CONTRIBUTE TO MARKET GROWTH
• 6.8 OTHER INJURIES

7 SPORTS MEDICINE MARKET, BY END USER

• 7.1 INTRODUCTION
• 7.2 HOSPITALS
  • 7.2.1 COMPLEX DIAGNOSTIC AND THERAPEUTIC PROCEDURES TO DRIVE MARKET
• 7.3 AMBULATORY SURGERY CENTERS
  • 7.3.1 LIMITED HOSPITALIZATION AND BETTER AFFORDABILITY TO AID GROWTH
• 7.4 PHYSIOTHERAPY CENTERS & CLINICS
  • 7.4.1 COST-EFFECTIVE AND NON-SURGICAL METHOD TO ACCELERATE GROWTH

8 SPORTS MEDICINE MARKET, BY PRODUCT

• 8.1 INTRODUCTION
• 8.2 REPAIR & RECONSTRUCTION PRODUCTS
  • 8.2.1 FRACTURE & LIGAMENT REPAIR PRODUCTS
    • 8.2.1.1 High incidence of sports and recreation-related trauma to encourage growth
  • 8.2.2 ARTHROSCOPY DEVICES
    • 8.2.2.1 Ability to minimize risk of infections and reduce recovery time to favor market growth
  • 8.2.3 IMPLANTS
    • 8.2.3.1 Growing popularity of minimally invasive surgical procedures to boost market
  • 8.2.4 ORTHOBIOLOGICS
    • 8.2.4.1 Ongoing research in regenerative medicine to promote growth
  • 8.2.5 PROSTHETICS
    • 8.2.5.1 Innovations in bionic technology, sensor technology, artificial intelligence, and micromechatronics to drive market
• 8.3 BODY SUPPORT & RECOVERY PRODUCTS
  • 8.3.1 BRACES & SUPPORTS
    • 8.3.1.1 Growing recommendations from physicians to augment growth
  • 8.3.2 PHYSIOTHERAPY EQUIPMENT
    • 8.3.2.1 Thermal therapy equipment
      • 8.3.2.1.1 Increasing availability of reusable hot and cold packs to expedite growth
    • 8.3.2.2 Electrostimulation equipment
      • 8.3.2.2.1 Growing advancements in electronics to propel market
    • 8.3.2.3 Other physiotherapy equipment
  • 8.3.3 COMPRESSION CLOTHING
    • 8.3.3.1 Surge in fitness centers and exercises in daily routines to speed up growth
• 8.4 ACCESSORIES
  • 8.4.1 NEED FOR INJURY PREVENTION AND MANAGEMENT TO SUPPORT GROWTH

9 SPORTS MEDICINE MARKET, BY REGION

• 9.1 INTRODUCTION
• 9.2 NORTH AMERICA
  • 9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 9.2.2 US
    • 9.2.2.1 Favorable research activities and funding to favor market growth
  • 9.2.3 CANADA
    • 9.2.3.1 Growing prominence of regenerative medicine and stem cell therapy to fuel market
• 9.3 EUROPE
  • 9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 9.3.2 GERMANY
    • 9.3.2.1 Increased participation in sports and awareness of healthy lifestyles to sustain growth
  • 9.3.3 UK
    • 9.3.3.1 Availability of funding for sports medicine and athlete support to boost market
  • 9.3.4 ITALY
    • 9.3.4.1 Rise in sports-related injuries to augment growth
  • 9.3.5 FRANCE
    • 9.3.5.1 Initiatives related to Olympics to contribute to market growth
  • 9.3.6 SPAIN
    • 9.3.6.1 Rising popularity of football and high risk of injuries to fuel market
  • 9.3.7 REST OF EUROPE
• 9.4 ASIA PACIFIC
  • 9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 9.4.2 JAPAN
    • 9.4.2.1 Rising number of total hip arthroplasty procedures and sports medicine fellowships to aid growth
  • 9.4.3 CHINA
    • 9.4.3.1 Growing focus on attaining higher fitness levels to drive market
  • 9.4.4 AUSTRALIA
    • 9.4.4.1 Surge in anterior cruciate ligament construction surgeries to encourage growth
  • 9.4.5 INDIA
    • 9.4.5.1 Booming sports infrastructure facilities to encourage growth
  • 9.4.6 SOUTH KOREA
    • 9.4.6.1 Favorable monetary support for sports-related activities to boost market
  • 9.4.7 REST OF ASIA PACIFIC
• 9.5 LATIN AMERICA
  • 9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 9.5.2 BRAZIL
    • 9.5.2.1 Growing number of international sports events to propel market
  • 9.5.3 MEXICO
    • 9.5.3.1 Growth of private healthcare facilities to fuel market
  • 9.5.4 REST OF LATIN AMERICA
• 9.6 MIDDLE EAST & AFRICA
  • 9.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 9.6.2 GCC COUNTRIES
    • 9.6.2.1 Strategic acquisitions and development of world-class stadiums to expedite growth
  • 9.6.3 REST OF MIDDLE EAST & AFRICA

10 COMPETITIVE LANDSCAPE

• 10.1 OVERVIEW
• 10.2 KEY PLAYER STRATEGY/RIGHT TO WIN
  • 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN SPORTS MEDICINE MARKET
• 10.3 REVENUE ANALYSIS, 2021-2024
• 10.4 MARKET SHARE ANALYSIS, 2023
• 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 10.5.1 STARS
  • 10.5.2 EMERGING LEADERS
  • 10.5.3 PERVASIVE PLAYERS
  • 10.5.4 PARTICIPANTS
  • 10.5.5 COMPANY FOOTPRINT
    • 10.5.5.1 Company footprint
    • 10.5.5.2 Product footprint
    • 10.5.5.3 Application footprint
    • 10.5.5.4 End-user footprint
    • 10.5.5.5 Region footprint
• 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
  • 10.6.1 PROGRESSIVE COMPANIES
  • 10.6.2 RESPONSIVE COMPANIES
  • 10.6.3 DYNAMIC COMPANIES
  • 10.6.4 STARTING BLOCKS
  • 10.6.5 COMPETITIVE BENCHMARKING
• 10.7 COMPANY VALUATION AND FINANCIAL METRICS
• 10.8 BRAND/PRODUCT COMPARISON
• 10.9 COMPETITIVE SCENARIO
  • 10.9.1 PRODUCT LAUNCHES AND APPROVALS
  • 10.9.2 DEALS
  • 10.9.3 EXPANSIONS

11 COMPANY PROFILES

• 11.1 KEY PLAYERS
  • 11.1.1 ARTHREX, INC.
    • 11.1.1.1 Business overview
    • 11.1.1.2 Products offered
    • 11.1.1.3 Recent developments
      • 11.1.1.3.1 Product launches and approvals
      • 11.1.1.3.2 Deals
    • 11.1.1.4 MnM view
      • 11.1.1.4.1 Right to win
      • 11.1.1.4.2 Strategic choices
      • 11.1.1.4.3 Weaknesses and competitive threats
  • 11.1.2 SMITH+NEPHEW
    • 11.1.2.1 Business overview
    • 11.1.2.2 Products offered
    • 11.1.2.3 Recent developments
      • 11.1.2.3.1 Product launches and approvals
      • 11.1.2.3.2 Deals
    • 11.1.2.4 MnM view
      • 11.1.2.4.1 Right to win
      • 11.1.2.4.2 Strategic choices
      • 11.1.2.4.3 Weaknesses and competitive threats
  • 11.1.3 STRYKER
    • 11.1.3.1 Business overview
    • 11.1.3.2 Products offered
    • 11.1.3.3 Recent developments
      • 11.1.3.3.1 Product launches and approvals
      • 11.1.3.3.2 Deals
      • 11.1.3.3.3 Expansions
    • 11.1.3.4 MnM view
      • 11.1.3.4.1 Right to win
      • 11.1.3.4.2 Strategic choices
      • 11.1.3.4.3 Weaknesses and competitive threats
  • 11.1.4 DEPUY SYNTHES
    • 11.1.4.1 Business overview
    • 11.1.4.2 Products offered
    • 11.1.4.3 Recent developments
      • 11.1.4.3.1 Product launches and approvals
      • 11.1.4.3.2 Deals
    • 11.1.4.4 MnM view
      • 11.1.4.4.1 Right to win
      • 11.1.4.4.2 Strategic choices
      • 11.1.4.4.3 Weaknesses and competitive threats
  • 11.1.5 ENOVIS
    • 11.1.5.1 Business overview
    • 11.1.5.2 Products offered
    • 11.1.5.3 Recent developments
      • 11.1.5.3.1 Product launches and approvals
      • 11.1.5.3.2 Deals
      • 11.1.5.3.3 Expansions
    • 11.1.5.4 MnM view
      • 11.1.5.4.1 Right to win
      • 11.1.5.4.2 Strategic choices
      • 11.1.5.4.3 Weaknesses and competitive threats
  • 11.1.6 BREG, INC.
    • 11.1.6.1 Business overview
    • 11.1.6.2 Products offered
    • 11.1.6.3 Recent developments
      • 11.1.6.3.1 Product launches and approvals
      • 11.1.6.3.2 Deals
  • 11.1.7 CONMED CORPORATION
    • 11.1.7.1 Business overview
    • 11.1.7.2 Products offered
    • 11.1.7.3 Recent developments
      • 11.1.7.3.1 Deals
  • 11.1.8 ZIMMER BIOMET
    • 11.1.8.1 Business overview
    • 11.1.8.2 Products offered
    • 11.1.8.3 Recent developments
      • 11.1.8.3.1 Product launches and approvals
      • 11.1.8.3.2 Deals
      • 11.1.8.3.3 Other developments
  • 11.1.9 RTI SURGICAL
    • 11.1.9.1 Business overview
    • 11.1.9.2 Products offered
    • 11.1.9.3 Recent developments
      • 11.1.9.3.1 Deals
      • 11.1.9.3.2 Other developments
  • 11.1.10 PERFORMANCE HEALTH
    • 11.1.10.1 Business overview
    • 11.1.10.2 Products offered
    • 11.1.10.3 Recent developments
      • 11.1.10.3.1 Deals
  • 11.1.11 BAUERFEIND
    • 11.1.11.1 Business overview
    • 11.1.11.2 Products offered
    • 11.1.11.3 Recent developments
      • 11.1.11.3.1 Product launches and approvals
  • 11.1.12 KARL STORZ
    • 11.1.12.1 Business overview
    • 11.1.12.2 Products offered
    • 11.1.12.3 Recent developments
      • 11.1.12.3.1 Deals
  • 11.1.13 MUELLER SPORTS MEDICINE, INC.
    • 11.1.13.1 Business overview
    • 11.1.13.2 Products offered
    • 11.1.13.3 Recent developments
      • 11.1.13.3.1 Deals
  • 11.1.14 OSSUR
    • 11.1.14.1 Business overview
    • 11.1.14.2 Products offered
    • 11.1.14.3 Recent developments
      • 11.1.14.3.1 Product launches and approvals
      • 11.1.14.3.2 Deals
      • 11.1.14.3.3 Expansions
  • 11.1.15 OTTOBOCK
    • 11.1.15.1 Business overview
    • 11.1.15.2 Products offered
    • 11.1.15.3 Recent developments
      • 11.1.15.3.1 Product launches and approvals
      • 11.1.15.3.2 Deals
  • 11.1.16 BIOTEK
    • 11.1.16.1 Business overview
    • 11.1.16.2 Products offered
  • 11.1.17 ANIKA THERAPEUTICS, INC.
    • 11.1.17.1 Business overview
    • 11.1.17.2 Products offered
• 11.2 OTHER PLAYERS
  • 11.2.1 BIOVENTUS
  • 11.2.2 MIACH ORTHOPAEDICS
  • 11.2.3 MONOGRAM ORTHOPEDICS
  • 11.2.4 EPIBONE
  • 11.2.5 ORTHALIGN
  • 11.2.6 BLUE OCEAN SPINE GMBH
  • 11.2.7 NELA BIODYNAMICS
  • 11.2.8 PARAGON 28, INC.
  • 11.2.9 ATEC SPINE, INC.
  • 11.2.10 MEDTRONIC

12 APPENDIX

• 12.1 DISCUSSION GUIDE
• 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 12.3 CUSTOMIZATION OPTIONS
• 12.4 RELATED REPORTS
• 12.5 AUTHOR DETAILS